[New treatment options for alcohol dependence].
Klinik für Psychiatrie und Psychotherapie, Campus Charité Mitte, Charité - Universitätsmedizin Berlin.
Christian A
CA
Müller
Klinik für Psychiatrie und Psychotherapie, Campus Charité Mitte, Charité - Universitätsmedizin Berlin.
Andreas
A
Heinz
D000077443:Acamprosate; D000437:Alcoholism / Q000534:rehabilitation*; D001418:Baclofen / Q000009:adverse effects / Q000627:therapeutic use; D003131:Combined Modality Therapy; D000431:Ethanol / Q000009:adverse effects; D005632:Fructose / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use; D006801:Humans; D009271:Naltrexone / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use; D011613:Psychotherapy; D055502:Secondary Prevention; D012960:Socioenvironmental Therapy; D013375:Substance Withdrawal Syndrome / Q000534:rehabilitation; D013654:Taurine / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use; D000077236:Topiramate
D000077236:Topiramate; D013654:Taurine; D005632:Fructose; D000431:Ethanol; D009271:Naltrexone; D001418:Baclofen; D000077443:Acamprosate; C038981:nalmefene